Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine

Anu Sharma,Anita Yadav,Aparajita Nandy,Subhadip Ghatak
DOI: https://doi.org/10.3390/pharmaceutics16060709
IF: 6.525
2024-05-25
Pharmaceutics
Abstract:Of all the numerous nanosized extracellular vesicles released by a cell, the endosomal-originated exosomes are increasingly recognized as potential therapeutics, owing to their inherent stability, low immunogenicity, and targeted delivery capabilities. This review critically evaluates the transformative potential of exosome-based modalities across pharmaceutical and precision medicine landscapes. Because of their precise targeted biomolecular cargo delivery, exosomes are posited as ideal candidates in drug delivery, enhancing regenerative medicine strategies, and advancing diagnostic technologies. Despite the significant market growth projections of exosome therapy, its utilization is encumbered by substantial scientific and regulatory challenges. These include the lack of universally accepted protocols for exosome isolation and the complexities associated with navigating the regulatory environment, particularly the guidelines set forth by the U.S. Food and Drug Administration (FDA). This review presents a comprehensive overview of current research trajectories aimed at addressing these impediments and discusses prospective advancements that could substantiate the clinical translation of exosomal therapies. By providing a comprehensive analysis of both the capabilities and hurdles inherent to exosome therapeutic applications, this article aims to inform and direct future research paradigms, thereby fostering the integration of exosomal systems into mainstream clinical practice.
pharmacology & pharmacy
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on the following aspects: 1. **Evaluating the potential of exosomes in drug innovation and precision medicine**: The paper discusses in detail the potential of exosomes as therapeutic carriers, especially their applications in drug delivery, regenerative medicine strategies, and diagnostic techniques. Exosomes are regarded as ideal therapeutic candidates because of their biological stability, low immunogenicity, and cell - specific targeting ability. 2. **Addressing the scientific and regulatory challenges faced by exosome therapy**: Although the exosome therapy market has broad growth prospects, its practical application still faces many scientific and regulatory challenges. These challenges include the lack of a generally accepted exosome isolation protocol and the complexity related to navigating the regulatory environment, especially the guidelines formulated by the US Food and Drug Administration (FDA). 3. **Promoting the clinical translation of exosome therapy**: The paper aims to provide guidance for future research directions by comprehensively analyzing the capabilities and inherent obstacles of exosome therapy, thereby promoting the integration of the exosome system in mainstream clinical practice. Specifically, the paper focuses on the following key points: - **Advantages of exosomes**: Exosomes have unique advantages in drug delivery, nucleic acid and vaccine therapy, such as high stability and low toxicity. - **Scientific challenges**: These include the standardized isolation technology of exosomes, the improvement of surface modification methods, and the improvement of targeting specificity and cargo delivery efficiency. - **Regulatory challenges**: It discusses the FDA's regulatory framework for exosome therapy and emphasizes the necessity of ensuring the safety and effectiveness of clinical applications. Through these analyses, the paper hopes to provide theoretical support and technical guidance for the future development of exosome therapy.